Paunovich Vukasin 4

What Happened

Vukasin Paunovich, Chief Technology Officer of LifeStance Health Group, was granted 86,331 restricted stock units (RSUs) on March 5, 2026. The Form 4 reports the acquisition as type "A" at $0.00 per share (total cash $0), meaning these are equity awards granted as compensation rather than an open-market purchase.

Key Details

• Transaction date: March 5, 2026; Form 4 filed March 9, 2026 (filed within the typical reporting window).
• Transaction type/code: A = Award/Grant (RSUs).
• Shares/units involved: 86,331 RSUs reported at $0.00 per unit.
• Shares owned after transaction: not specified in this filing.
• Footnote: F1 clarifies each RSU is a contingent right to receive one share of common stock upon vesting.
• No 10b5-1 plan, sale, tax-withholding disposition, or cash exercise noted in this filing.

Context

RSUs are a form of equity compensation that convert to actual shares only if and when they vest (they do not represent immediately tradable stock). Grants are common for executive compensation and retention; they are informative about pay but are not the same as an insider buying shares with cash.